Literature DB >> 20950147

Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi.

Vijay Bansode1, Zuzanna J Drebert, Simon A A Travers, Emmanuel Banda, Anna Molesworth, Amelia Crampin, Bagrey Ngwira, Neil French, Judith R Glynn, Grace P McCormack.   

Abstract

In this preliminary study we show that in 2008, 3 years after antiretroviral therapy was introduced into the Karonga District, Malawi, a greater than expected number of drug-naive individuals have been infected with HIV-1 subtype C virus harboring major and minor drug resistance mutations (DRMs). From a sample size of 40 reverse transcriptase (RT) consensus sequences from drug-naive individuals we found five showing NRTI and four showing NNRTI mutations with one individual showing both. From 29 protease consensus sequences, again from drug-naive individuals, we found evidence of minor DRMs in three. Additional major and minor DRMs were found in clonal sequences from a number of individuals that were not present in the original consensus sequences. This clearly illustrates the importance of sequencing multiple HIV-1 variants from individuals to fully assess drug resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950147      PMCID: PMC3068870          DOI: 10.1089/aid.2010.0203

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

Review 1.  Death by deamination: a novel host restriction system for HIV-1.

Authors:  Stephen P Goff
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

2.  G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.

Authors:  Tara L Kieffer; Patty Kwon; Richard E Nettles; Yefei Han; Stuart C Ray; Robert F Siliciano
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals.

Authors:  Pascal O Bessong; Jeffrey Mphahlele; Isaac A Choge; Larry C Obi; Lynn Morris; Marie-Louise Hammarskjold; David M Rekosh
Journal:  AIDS Res Hum Retroviruses       Date:  2006-12       Impact factor: 2.205

4.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

5.  Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Authors:  Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

6.  Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi.

Authors:  L A Petch; I F Hoffman; C S Jere; P N Kazembe; F E Martinson; D Chilongozi; S A Fiscus; M S Cohen
Journal:  AIDS Res Hum Retroviruses       Date:  2005-09       Impact factor: 2.205

7.  Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi.

Authors:  Grace P McCormack; Judith R Glynn; Amelia C Crampin; Felix Sibande; Dominic Mulawa; Lyn Bliss; Philip Broadbent; Katia Abarca; Jorg M Pönnighaus; Paul E M Fine; Jonathan P Clewley
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.

Authors:  Ray Handema; Hiroshi Terunuma; Francis Kasolo; Hirotake Kasai; Moses Sichone; Atsuya Yamashita; Xuewen Deng; Georgina Mulundu; Kouji Ichiyama; Mwansa Munkanta; Tomoyuki Yokota; Naomi Wakasugi; Fumiaki Tezuka; Naoki Yamamoto; Masahiko Ito
Journal:  AIDS Res Hum Retroviruses       Date:  2003-02       Impact factor: 2.205

9.  Human immunodeficiency virus reverse transcriptase and protease sequence database.

Authors:  Soo-Yon Rhee; Matthew J Gonzales; Rami Kantor; Bradley J Betts; Jaideep Ravela; Robert W Shafer
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

10.  The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

Authors:  Mina C Hosseinipour; Joep J G van Oosterhout; Ralf Weigel; Sam Phiri; Debbie Kamwendo; Neil Parkin; Susan A Fiscus; Julie A E Nelson; Joseph J Eron; Johnstone Kumwenda
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

View more
  5 in total

Review 1.  Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.

Authors:  Kathryn M Stadeli; Douglas D Richman
Journal:  Antivir Ther       Date:  2012-10-10

2.  Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi.

Authors:  Vijay B Bansode; Simon Aa Travers; Amelia C Crampin; Bagrey Ngwira; Neil French; Judith R Glynn; Grace P McCormack
Journal:  AIDS Res Ther       Date:  2011-10-13       Impact factor: 2.250

3.  Profile: the Karonga Health and Demographic Surveillance System.

Authors:  Amelia C Crampin; Albert Dube; Sebastian Mboma; Alison Price; Menard Chihana; Andreas Jahn; Angela Baschieri; Anna Molesworth; Elnaeus Mwaiyeghele; Keith Branson; Sian Floyd; Nuala McGrath; Paul E M Fine; Neil French; Judith R Glynn; Basia Zaba
Journal:  Int J Epidemiol       Date:  2012-06-22       Impact factor: 7.196

4.  Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.

Authors:  Nalia Ismael; Eduan Wilkinson; Isabel Mahumane; Hernane Gemusse; Jennifer Giandhari; Adilson Bauhofer; Adolfo Vubil; Pirolita Mambo; Lavanya Singh; Nédio Mabunda; Dulce Bila; Susan Engelbrecht; Eduardo Gudo; Richard Lessells; Túlio de Oliveira
Journal:  Viruses       Date:  2022-09-09       Impact factor: 5.818

5.  Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing.

Authors:  Vijay Bansode; Grace P McCormack; Amelia C Crampin; Bagrey Ngwira; Ram K Shrestha; Neil French; Judith R Glynn; Simon A Travers
Journal:  BMC Infect Dis       Date:  2013-01-30       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.